News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,853 Results
Type
Article (14235)
Company Profile (294)
Press Release (247324)
Section
Business (79864)
Career Advice (147)
Deals (13301)
Drug Delivery (38)
Drug Development (50999)
Employer Resources (31)
FDA (5797)
Job Trends (5203)
News (145499)
Policy (10253)
Tag
Academia (905)
Alliances (21612)
Alzheimer's disease (777)
Antibody-drug conjugate (ADC) (75)
Approvals (5742)
Artificial intelligence (64)
Bankruptcy (98)
Best Places to Work (4567)
Biotechnology (242)
Breast cancer (73)
Cancer (673)
Cardiovascular disease (52)
Career advice (128)
CAR-T (53)
Cell therapy (164)
Clinical research (40227)
Collaboration (214)
Compensation (86)
COVID-19 (1028)
C-suite (61)
Cystic fibrosis (61)
Data (681)
Diabetes (72)
Diagnostics (1205)
Earnings (28990)
Events (47098)
Executive appointments (158)
FDA (6054)
Funding (215)
Gene editing (52)
Gene therapy (133)
GLP-1 (304)
Government (1096)
Healthcare (6700)
Infectious disease (1060)
Inflammatory bowel disease (89)
IPO (7230)
Job creations (868)
Job search strategy (124)
Layoffs (187)
Legal (1392)
Lung cancer (126)
Manufacturing (75)
Medical device (2563)
Medtech (2564)
Mergers & acquisitions (6156)
Metabolic disorders (219)
Neuroscience (961)
NextGen Class of 2024 (2020)
Non-profit (851)
Northern California (851)
Obesity (121)
Opinion (94)
Parkinson's disease (56)
Patents (51)
People (25016)
Pharmaceutical (48)
Phase I (14130)
Phase II (18655)
Phase III (11938)
Pipeline (225)
Postmarket research (855)
Preclinical (5939)
Radiopharmaceuticals (207)
Rare diseases (146)
Real estate (1435)
Regulatory (8383)
Research institute (938)
Southern California (776)
Startups (1966)
United States (7037)
Vaccines (170)
Weight loss (78)
Date
Today (153)
Last 7 days (642)
Last 30 days (2016)
Last 365 days (20939)
2024 (18444)
2023 (22700)
2022 (27106)
2021 (28009)
2020 (23554)
2019 (16440)
2018 (11903)
2017 (13868)
2016 (11937)
2015 (14469)
2014 (10475)
2013 (7562)
2012 (7609)
2011 (7669)
2010 (7470)
Location
Africa (153)
Asia (17101)
Australia (2834)
California (1916)
Canada (665)
China (152)
Colorado (70)
Connecticut (76)
Europe (36511)
Florida (204)
Georgia (55)
Illinois (118)
Indiana (53)
Kansas (55)
Maryland (285)
Massachusetts (1582)
Minnesota (85)
New Jersey (529)
New York (569)
North Carolina (386)
Northern California (851)
Ohio (73)
Pennsylvania (394)
South America (214)
Southern California (776)
Texas (197)
Washington State (222)
261,853 Results for "adc therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC
November 7, 2024
·
3 min read
Press Releases
ADC Therapeutics to Present at November 2024 Investor Conferences
November 5, 2024
·
1 min read
ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will present a company overview at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 11:30 a.m. ET.
May 30, 2024
·
4 min read
ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes - June 27, 2024
ADC Therapeutics SA announced that the Company is set to join the Russell 2000® Index and the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024.
June 27, 2024
·
5 min read
Press Releases
ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting
November 6, 2024
·
6 min read
Press Releases
ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024
October 31, 2024
·
4 min read
Press Releases
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
October 1, 2024
·
4 min read
Business
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
ADC Therapeutics SA reported financial results for the first quarter ended March 31, 2024, and provided business updates.
May 6, 2024
·
22 min read
Press Releases
Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference
November 4, 2024
·
1 min read
Deals
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - June 3, 2024
ADC Therapeutics SA (NYSE: ADCT) today announced that the Company has made grants of options to purchase an aggregate of 109,800 of the Company’s common shares to three new employees on June 3, 2024 (each, a “Grant”).
June 3, 2024
·
5 min read
1 of 26,186
Next
